News
Ambarella (AMBA) Surpasses Q3 Earnings and Revenue Estimates
Ambarella (AMBA) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.11 per share a year ago. These figures
Dell Technologies (DELL) Surpasses Q3 Earnings Estimates
Dell Technologies (DELL) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $2.15 per share a year ago. These
PagerDuty (PD) Q3 Earnings Surpass Estimates
PagerDuty (PD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.25 per share a year ago. These figures
Zscaler (ZS) Beats Q1 Earnings and Revenue Estimates
Zscaler (ZS) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.77 per share a year ago. These figures are
Urban Outfitters (URBN) Q3 Earnings and Revenues Surpass Estimates
Urban Outfitters (URBN) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.1 per share a year ago. These
Nutanix (NTNX) Matches Q1 Earnings Estimates
Nutanix (NTNX) came out with quarterly earnings of $0.41 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.42 per share a year ago. These figures are adjusted
Autodesk (ADSK) Q3 Earnings and Revenues Beat Estimates
Autodesk (ADSK) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.49 per share. This compares to earnings of $2.17 per share a year ago. These figures
Workday (WDAY) Q3 Earnings and Revenues Beat Estimates
Workday (WDAY) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $1.89 per share a year ago. These figures
NetApp (NTAP) Q2 Earnings and Revenues Beat Estimates
NetApp (NTAP) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.87 per share a year ago. These figures are
Top Analyst Reports for NVIDIA, AT&T & Amgen
Tuesday, November 25, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA
Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Risks remain, but the S&P 500’s (NYSEARCA: SPY) uptrend is intact. The November correction was more of a broad-market consolidation, setting the market up for another leg of the rally, likely to
Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?
Over $500 million in insider stock sales have hit three high-profile companies this month—an unsettling signal that even top executives and major stakeholders may be questioning the sustainability
The Best Momentum Stocks to Buy in December
The artificial intelligence bulls stepped back into the market on Monday, after they began testing the waters on Friday following the rapid pullback. The bulls are currently attempting to push the
BP's Olympic Pipeline Shutdown Impacts Refined Product Supplies
BP plc BP, the London-listed oil and gas major, has shut down its Olympic Pipeline system after identifying a leak in the pipeline, following which jet fuel supplies to the Seattle-Tacoma airport
Here's Why EVRG Stock Deserves a Spot in Your Portfolio Right Now
Evergy, Inc. EVRG is expanding its operations in the transmission market through collaborations, strategic acquisitions and partnerships. The company also aims to add more renewable assets to its
BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi
Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T
XOM Halts Plans for Massive Blue Hydrogen Plant Amid Weak Demand
Exxon Mobil Corporation (XOM), a U.S. oil and gas giant, stated that it has put a hold on its plans for the construction of the blue hydrogen facility in Baytown, TX, intended to be the largest of
FDA Greenlights Novartis' Gene Replacement Treatment for SMA
Novartis NVS obtained FDA approval for onasemnogene abeparvovec-brve, a gene replacement therapy, for children two years and older, teens, and adults with spinal muscular atrophy (SMA).
The therapy
GOOGL vs. NVDA: Is There a New Leader in AI?
Just a few months ago, analysts and investors were openly questioning Alphabet’s (GOOGL) future, arguing that large language models would cannibalize search and erode its core business. Today, the
Missed the AI Boom? These 2 Crushed Stocks Could Be Your Second Chance
Last month, when concerns about an AI bubble spilled over and sparked a sell-off, stocks spent several weeks in a pullback. However, the fallout adversely affected some equities more than
ANF Stock Up on Q3 Earnings Beat, Higher Sales on Growth Across Regions
Abercrombie & Fitch Co. ANF posted strong third-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Additionally, on a year-over-year basis, the
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
Shares of Sarepta Therapeutics SRPT rose 7% on Monday after the company announced its progress on a phase I/II study evaluating SRP-1003, an investigational small interfering RNA (siRNA) therapeutic
Is MA Using Beauty Commerce to Unlock Its Next SME Growth Wave?
Mastercard Incorporated MA is diving deeper into sector-specific commerce innovation, and its latest collaboration with L’Oréal could signal a significant change in how beauty products are financed
Apple Bull Case: Vertical Integration, AI Efficiency, & a Huge Cash Stack
Zacks Rank #3 (Hold) stock Apple (AAPL) has undergone dramatic changes throughout its long and storied history. Initially, the company focused on computers, but today, its business primarily